Zealand Pharma A/S (LON:0NZU)
London flag London · Delayed Price · Currency is GBP · Price in DKK
403.40
-16.85 (-4.01%)
At close: Feb 11, 2026

Zealand Pharma Revenue

Zealand Pharma had revenue of 49.57M DKK in the quarter ending September 30, 2025, with 1,022.74% growth. This brings the company's revenue in the last twelve months to 9.16B, up 11,809.72% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.

Revenue (ttm)
9.16B DKK
Revenue Growth
+11,809.72%
P/S Ratio
3.14
Revenue / Employee
20.81M DKK
Employees
440
Market Cap
3.36B GBP

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202462.69M-280.10M-81.71%
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
easyJet10.11B
Balfour Beatty8.87B
Computacenter7.85B
Harbour Energy6.99B
ITV plc3.47B
RS Group2.87B
Hikma Pharmaceuticals2.35B
Hochschild Mining785.35M
Revenue Rankings